ArticleRSC advances2012
A potential nanobiotechnology platform based on infectious bursal disease subviral particles.
Omid Taghavian et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleRSC advances2012
Omid Taghavian et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.